Jejunal Leptin-PI3K Signaling Lowers Glucose Production

Slides:



Advertisements
Similar presentations
Differential effects of angiopoietin-like 4 in brain and muscle on regulation of lipoprotein lipase activity  Sara Gry Vienberg, André Kleinridders, Ryo.
Advertisements

Volume 10, Issue 4, Pages (October 2009)
Volume 14, Issue 2, Pages (August 2011)
Volume 20, Issue 5, Pages (November 2014)
Beatrice M. Filippi, Clair S. Yang, Christine Tang, Tony K.T. Lam 
Volume 142, Issue 4, Pages e3 (April 2012)
Volume 10, Issue 2, Pages (August 2009)
Volume 18, Issue 3, Pages (September 2013)
Volume 8, Issue 3, Pages (September 2008)
A Sweet Spot for the Bariatric Surgeon
Volume 141, Issue 5, Pages (November 2011)
Bariatric Surgery Restores Gut-Brain Signaling to Reduce Fat Intake
Volume 7, Issue 4, Pages (April 2008)
Safia Costes, Peter C. Butler  Cell Metabolism 
A Flt3L Encounter: mTOR Signaling in Dendritic Cells
Ling Yang, Ping Li, Suneng Fu, Ediz S. Calay, Gökhan S. Hotamisligil 
Brain Insulin Controls Adipose Tissue Lipolysis and Lipogenesis
Volume 11, Issue 5, Pages (May 2010)
Volume 2, Issue 5, Pages (November 2005)
Volume 142, Issue 4, Pages e3 (April 2012)
Volume 27, Issue 1, Pages e5 (January 2018)
Volume 18, Issue 3, Pages (September 2013)
Grzegorz Sumara, Olga Sumara, Jason K. Kim, Gerard Karsenty 
Volume 6, Issue 3, Pages (September 2007)
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Independent Control of Aging and Axon Regeneration
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 10, Issue 2, Pages (August 2009)
The CAMplexities of Central Ghrelin
Volume 18, Issue 6, Pages (December 2013)
Volume 1, Issue 5, Pages (May 2005)
Making Biological Sense of GWAS Data: Lessons from the FTO Locus
A New Biology of Diabetes Revealed by Leptin
Insulin Signaling in α Cells Modulates Glucagon Secretion In Vivo
Selective Insulin and Leptin Resistance in Metabolic Disorders
Antidiabetic Effects of IGFBP2, a Leptin-Regulated Gene
Diet-Induced Obese Mice Retain Endogenous Leptin Action
Regulation of Hepatic Energy Metabolism and Gluconeogenesis by BAD
Volume 23, Issue 6, Pages (June 2016)
Volume 9, Issue 2, Pages (February 2009)
Volume 23, Issue 3, Pages (March 2016)
Volume 9, Issue 5, Pages (May 2009)
Volume 11, Issue 3, Pages (March 2010)
Volume 10, Issue 1, Pages (July 2009)
Volume 8, Issue 4, Pages (October 2008)
Volume 25, Issue 4, Pages e4 (April 2017)
Volume 18, Issue 10, Pages (March 2017)
Volume 9, Issue 1, Pages (January 2009)
Volume 2, Issue 5, Pages (November 2005)
Volume 15, Issue 5, Pages (May 2012)
Volume 6, Issue 5, Pages (November 2007)
A Sweet Spot for the Bariatric Surgeon
Volume 2, Issue 2, Pages (August 2005)
Critical role of STAT3 in leptin's metabolic actions
Volume 9, Issue 5, Pages (May 2009)
Induction of Leptin Resistance by Activation of cAMP-Epac Signaling
Identification of SH2-B as a key regulator of leptin sensitivity, energy balance, and body weight in mice  Decheng Ren, Minghua Li, Chaojun Duan, Liangyou.
Volume 14, Issue 2, Pages (August 2011)
Volume 5, Issue 6, Pages (June 2007)
Mice with AS160/TBC1D4-Thr649Ala Knockin Mutation Are Glucose Intolerant with Reduced Insulin Sensitivity and Altered GLUT4 Trafficking  Shuai Chen, David.
Volume 26, Issue 5, Pages e3 (November 2017)
Volume 3, Issue 1, Pages (January 2006)
Volume 2, Issue 2, Pages (August 2005)
Role reversal: Brain insulin and liver STAT3
Clémence Blouet, Hiraku Ono, Gary J. Schwartz  Cell Metabolism 
Volume 26, Issue 2, Pages e3 (January 2019)
AMPK and p53 help cells through lean times
Estrogens and Obesity: Is It All in Our Heads?
Evidence against a Physiologic Role for Acute Changes in CNS Insulin Action in the Rapid Regulation of Hepatic Glucose Production  Christopher J. Ramnanan,
Volume 4, Issue 4, Pages (October 2006)
Presentation transcript:

Jejunal Leptin-PI3K Signaling Lowers Glucose Production Brittany A. Rasmussen, Danna M. Breen, Frank A. Duca, Clémence D. Côté, Melika Zadeh-Tahmasebi, Beatrice M. Filippi, Tony K.T. Lam  Cell Metabolism  Volume 19, Issue 1, Pages 155-161 (January 2014) DOI: 10.1016/j.cmet.2013.11.014 Copyright © 2014 Elsevier Inc. Terms and Conditions

Cell Metabolism 2014 19, 155-161DOI: (10.1016/j.cmet.2013.11.014) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 1 Jejunal Leptin Activates Leptin Receptors to Lower GP in Rats and Mice (A) Schematic representation of the working hypothesis: gastric leptin activates an intestinal Leprb receptor-PI3K- and/or STAT3-dependent pathway to regulate GP via a neuronal network. (B and C) We measured the glucose infusion rate (B) and glucose production (C) during the clamp (∗∗p < 0.01 jejunal leptin versus other groups). (D) Plasma leptin levels before (basal) and at the end of the clamp. Portal leptin levels at the end of the clamp. (E) Glucose production during the clamp in lean (Fa/Fa) or leptin receptor-deficient obese (fak/fak) Koletsky rats (∗∗p < 0.01 versus other groups). (F) Glucose production during the clamp in C57BL/6 or leptin receptor-deficient db/db mice (∗∗p < 0.01 versus other groups). Values are shown as mean + SEM. n = 5–7 rats per group; n = 7–8 mice per group. SLR, soluble leptin receptor. See also Figure S1 and Table S1. Cell Metabolism 2014 19, 155-161DOI: (10.1016/j.cmet.2013.11.014) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 2 Jejunal Leptin Activates a STAT3-Independent and PI3K-Dependent Pathway to Lower GP via a Neuronal Network (A and B) We measured the glucose infusion rate (A) and glucose production (B) during the clamp (∗∗p < 0.01 leptin or leptin + STAT3 PI versus other groups). (C) The level of phosphorylation of STAT3 analyzed by western blot and expressed as fold increase over saline in the jejunum obtained at the end of the clamp (∗p < 0.05 versus other groups). A representative immunoblot is shown. (D) PI3K activity in the jejunum at the end of the clamp expressed as fold increase over saline (∗p < 0.05 versus other groups). (E and F) We measured the glucose infusion rate (E) and glucose production (F) during the clamp (∗∗p < 0.01 versus other groups). Values are shown as mean + SEM. n = 5–7 rats per group. STAT3 PI, signal transducer and activator of transcription 3 peptide inhibitor; PI3K, phosphatidylinositol 3-kinase. See also Figure S2. Cell Metabolism 2014 19, 155-161DOI: (10.1016/j.cmet.2013.11.014) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 3 Jejunal Leptin Lowers GP in High-Fat-Fed or Uncontrolled Diabetic Rats (A and B) We measured the glucose production (A) and the percent suppression of glucose production (B) during the clamp (∗∗p < 0.01 leptin versus saline). (C–F) We measured the plasma glucose levels (C), glucose production (D), plasma insulin (E), and glucagon levels (F) in nonclamped conditions in STZ-diabetic rats (∗p < 0.05 leptin versus saline). Values are shown as mean + SEM. n = 5–6 rats per group. STZ, streptozotocin. See also Figure S3. Cell Metabolism 2014 19, 155-161DOI: (10.1016/j.cmet.2013.11.014) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 4 Jejunal Leptin Action Mediates the Rapid Antidiabetic Effect of DJB (A) Schematic representation of the sham and DJB surgical procedure and jejunal catheter placement. (B) Fed plasma glucose levels obtained in STZ-induced diabetic rats 2 days after sham or DJB surgery (∗p < 0.05). (C and D) Fed plasma insulin (C) and glucagon (D) levels obtained in rats before STZ injection, after STZ injection (before surgery), and 2 days after surgery (in C, ∗∗p < 0.01 versus other groups). (E) Top: plasma glucose levels during refeeding in STZ-diabetic rats with DJB versus SHAM surgery and infused with intrajejunal saline. Bottom: plasma glucose levels during refeeding in STZ-diabetic rats with DJB surgery and infused with intrajejunal saline or the SLR (ϕ = STZ-DJB-jejunal saline versus STZ-SHAM-jejunal saline; ∗ = STZ-DJB-jejunal saline versus STZ-DJB-jejunal SLR; ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.001, ∗∗∗∗p < 0.0001 [same for both symbols]). (F) Accumulated food intake during the refeeding protocol. Values are shown as mean + SEM. n = 5–6 rats per group. Cell Metabolism 2014 19, 155-161DOI: (10.1016/j.cmet.2013.11.014) Copyright © 2014 Elsevier Inc. Terms and Conditions